Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07133464 · ClinicalTrials.gov registry record
CDH1-associated Blepharocheilodontic Syndrome Registry
A clinical trial of Blepharocheilodontic Syndrome, sponsored by Ohio State University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07133464 is a study of Blepharocheilodontic Syndrome that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07133464, a study of Blepharocheilodontic Syndrome, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the CDH1-associated Blepharocheilodontic Syndrome (BCDS) registry is to better characterize the clinical features of this condition and exploring whether CDH1 variants linked to BCDS may also increase cancer risk.
Conditions Studied
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2040-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07133464
The ClinicalTrials.gov registry entry for NCT07133464 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blepharocheilodontic Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT07133464 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07133464 about?
NCT07133464 is a clinical study titled "CDH1-associated Blepharocheilodontic Syndrome Registry". The aim of the CDH1-associated Blepharocheilodontic Syndrome (BCDS) registry is to better characterize the clinical features of this condition and exploring whether CDH1 variants linked to BCDS may also increase cancer risk.
What is the current status of trial NCT07133464?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-06-17. Estimated completion is 2040-01.
What conditions does trial NCT07133464 study?
This clinical trial studies the following conditions: Blepharocheilodontic Syndrome.
Who is sponsoring clinical trial NCT07133464?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07133464 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.